Mitochondrial dysfunction is associated with various chronic diseases and cancers, including neurodegenerative diseases and ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at ...

Miller Reynolds is a Journalist and Writer with a strong passion for gaming and writing news. Awarded the Excellence in Writing and Production Award while attending Loyalist College, Miller is ...

Parse Biosciences co-founders are CTO Charles Roco and CEO Alex Rosenberg. (Parse Photo) Seattle’s Parse Biosciences is teed up for an acquisition by Qiagen, a Netherlands-based holding company, in a ...

The news is coming thick and fast for Qiagen. As the molecular diagnostics specialist announced its third-quarter earnings, it also revealed that its long-term chief executive, Thierry Bernard, will ...

Parse Biosciences is a fast-growing innovator in single-cell sample preparation, with technologies used in more than 3,000 labs across over 40 countries Acquisition strengthens QIAGEN’s presence in ...

New EZ2 DNA Investigator Sep&Prep Kit automates sexual assault sample processing, improving sperm DNA recovery and separation from victim DNA Workflow on EZ2 Connect Fx delivers high-quality DNA in ...

Tim Wu’s “The Age of Extraction” is a dispiriting guide to the way Silicon Valley has warped our markets and our democracy. By Jennifer Szalai When you purchase an independently reviewed book through ...

Netflix‘s upcoming new series Extraction is rounding out the cast with Sacha Dhawan (The Great), Ross McCall (Silo), Pip Torrens (The Crown), Sam Woolf (We Were the Lucky Ones), Michael Zananiri (Once ...

Chris is a Senior News Writer for Collider. He can be found in an IMAX screen, with his eyes watering and his ears bleeding for his own pleasure. He joined the news team in 2022 and accidentally fell ...

Diagnostics now outperform Life Sciences due to academic funding cuts, making Qiagen's defensive profile more attractive in the current market. Qiagen offers stable growth, high profitability, and low ...